These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 35526388)

  • 41. R534C mutation in hERG causes a trafficking defect in iPSC-derived cardiomyocytes from patients with type 2 long QT syndrome.
    Mesquita FCP; Arantes PC; Kasai-Brunswick TH; Araujo DS; Gubert F; Monnerat G; Silva Dos Santos D; Neiman G; Leitão IC; Barbosa RAQ; Coutinho JL; Vaz IM; Dos Santos MN; Borgonovo T; Cruz FES; Miriuka S; Medei EH; Campos de Carvalho AC; Carvalho AB
    Sci Rep; 2019 Dec; 9(1):19203. PubMed ID: 31844156
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mutation and gender-specific risk in type 2 long QT syndrome: implications for risk stratification for life-threatening cardiac events in patients with long QT syndrome.
    Migdalovich D; Moss AJ; Lopes CM; Costa J; Ouellet G; Barsheshet A; McNitt S; Polonsky S; Robinson JL; Zareba W; Ackerman MJ; Benhorin J; Kaufman ES; Platonov PG; Shimizu W; Towbin JA; Vincent GM; Wilde AA; Goldenberg I
    Heart Rhythm; 2011 Oct; 8(10):1537-43. PubMed ID: 21440677
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pharmacological correction of long QT-linked mutations in KCNH2 (hERG) increases the trafficking of Kv11.1 channels stored in the transitional endoplasmic reticulum.
    Smith JL; Reloj AR; Nataraj PS; Bartos DC; Schroder EA; Moss AJ; Ohno S; Horie M; Anderson CL; January CT; Delisle BP
    Am J Physiol Cell Physiol; 2013 Nov; 305(9):C919-30. PubMed ID: 23864605
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Novel intracellular transport-refractory mutations in KCNH2 identified in patients with symptomatic long QT syndrome.
    Fukumoto D; Ding WG; Wada Y; Fujii Y; Ichikawa M; Takayama K; Fukuyama M; Kato K; Itoh H; Makiyama T; Omatsu-Kanbe M; Matsuura H; Horie M; Ohno S
    J Cardiol; 2018 Apr; 71(4):401-408. PubMed ID: 29146210
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Aborted Cardiac Arrest in LQT2 Related to Novel
    Bileišienė N; Barysienė J; Mikštienė V; Preikšaitienė E; Marinskis G; Keževičiūtė M; Utkus A; Aidietis A
    Medicina (Kaunas); 2021 Jul; 57(7):. PubMed ID: 34357002
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mechanistic basis for type 2 long QT syndrome caused by KCNH2 mutations that disrupt conserved arginine residues in the voltage sensor.
    McBride CM; Smith AM; Smith JL; Reloj AR; Velasco EJ; Powell J; Elayi CS; Bartos DC; Burgess DE; Delisle BP
    J Membr Biol; 2013 May; 246(5):355-64. PubMed ID: 23546015
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Non-missense variants of KCNH2 show better outcomes in type 2 long QT syndrome.
    Aizawa T; Wada Y; Hasegawa K; Huang H; Imamura T; Gao J; Kashiwa A; Kohjitani H; Fukuyama M; Kato K; Kato ET; Hisamatsu T; Ohno S; Makiyama T; Kimura T; Horie M
    Europace; 2023 Apr; 25(4):1491-1499. PubMed ID: 36861347
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Drug evaluation in cardiomyocytes derived from human induced pluripotent stem cells carrying a long QT syndrome type 2 mutation.
    Matsa E; Rajamohan D; Dick E; Young L; Mellor I; Staniforth A; Denning C
    Eur Heart J; 2011 Apr; 32(8):952-62. PubMed ID: 21367833
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Overlapping LQT1 and LQT2 phenotype in a patient with long QT syndrome associated with loss-of-function variations in KCNQ1 and KCNH2.
    Cordeiro JM; Perez GJ; Schmitt N; Pfeiffer R; Nesterenko VV; Burashnikov E; Veltmann C; Borggrefe M; Wolpert C; Schimpf R; Antzelevitch C
    Can J Physiol Pharmacol; 2010 Dec; 88(12):1181-90. PubMed ID: 21164565
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Most LQT2 mutations reduce Kv11.1 (hERG) current by a class 2 (trafficking-deficient) mechanism.
    Anderson CL; Delisle BP; Anson BD; Kilby JA; Will ML; Tester DJ; Gong Q; Zhou Z; Ackerman MJ; January CT
    Circulation; 2006 Jan; 113(3):365-73. PubMed ID: 16432067
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Novel mutation in the Per-Arnt-Sim domain of KCNH2 causes a malignant form of long-QT syndrome.
    Rossenbacker T; Mubagwa K; Jongbloed RJ; Vereecke J; Devriendt K; Gewillig M; Carmeliet E; Collen D; Heidbüchel H; Carmeliet P
    Circulation; 2005 Mar; 111(8):961-8. PubMed ID: 15699249
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Generation of a KCNQ1 (c.1032 + 2 T > C) mutant human embryonic stem cell line via CRISPR base editing.
    Jiang X; Fu C; Liu Q; Gao J
    Stem Cell Res; 2024 Jun; 77():103425. PubMed ID: 38653148
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Contribution of a KCNH2 variant in genotyped long QT syndrome: Romano-Ward syndrome under double mutations and acquired long QT syndrome under heterozygote.
    Fujii Y; Matsumoto Y; Hayashi K; Ding WG; Tomita Y; Fukumoto D; Wada Y; Ichikawa M; Sonoda K; Ozawa J; Makiyama T; Ohno S; Yamagishi M; Matsuura H; Horie M; Itoh H
    J Cardiol; 2017 Jul; 70(1):74-79. PubMed ID: 27816319
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Functional analysis of KCNH2 gene mutations of type 2 long QT syndrome in larval zebrafish using microscopy and electrocardiography.
    Tanaka Y; Hayashi K; Fujino N; Konno T; Tada H; Nakanishi C; Hodatsu A; Tsuda T; Nagata Y; Teramoto R; Yoshida S; Nomura A; Kawashiri MA; Yamagishi M
    Heart Vessels; 2019 Jan; 34(1):159-166. PubMed ID: 30047011
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Heterogeneous Phenotype of Long QT Syndrome Caused by the KCNH2-H562R Mutation: Importance of Familial Genetic Testing.
    Muñoz-Esparza C; García-Molina E; Salar-Alcaraz M; Peñafiel-Verdú P; Sánchez-Muñoz JJ; Martínez Sánchez J; Cabañas-Perianes V; Valdés Chávarri M; García Alberola A; Gimeno-Blanes JR
    Rev Esp Cardiol (Engl Ed); 2015 Oct; 68(10):861-8. PubMed ID: 25819988
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Common variants in the hERG (KCNH2) voltage-gated potassium channel are associated with altered fasting and glucose-stimulated plasma incretin and glucagon responses.
    Engelbrechtsen L; Mahendran Y; Jonsson A; Gjesing AP; Weeke PE; Jørgensen ME; Færch K; Witte DR; Holst JJ; Jørgensen T; Grarup N; Pedersen O; Vestergaard H; Torekov S; Kanters JK; Hansen T
    BMC Genet; 2018 Mar; 19(1):15. PubMed ID: 29548277
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Novel mutations of potassium channel KCNQ1 S145L and KCNH2 Y475C genes in Chinese pedigrees of long QT syndrome].
    Liu WL; Hu DY; Li P; Li CL; Qin XG; Li YT; Li L; Li ZM; Dong W; Qi Y; Wang Q
    Zhonghua Nei Ke Za Zhi; 2006 Jun; 45(6):463-6. PubMed ID: 16831322
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Establishment of a human induced pluripotent stem cell line, KSCBi015-A, from a long QT syndrome type 1 patient harboring a KCNQ1 mutation.
    Lee Y; Park H; Kyung Koo S; Kim JH
    Stem Cell Res; 2021 Oct; 56():102521. PubMed ID: 34509919
    [TBL] [Abstract][Full Text] [Related]  

  • 59. KCNH2-K897T is a genetic modifier of latent congenital long-QT syndrome.
    Crotti L; Lundquist AL; Insolia R; Pedrazzini M; Ferrandi C; De Ferrari GM; Vicentini A; Yang P; Roden DM; George AL; Schwartz PJ
    Circulation; 2005 Aug; 112(9):1251-8. PubMed ID: 16116052
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Quantitative T-wave morphology assessment from surface ECG is linked with cardiac events risk in genotype-positive KCNH2 mutation carriers with normal QTc values.
    Cortez D; Zareba W; McNitt S; Polonsky B; Rosero SZ; Platonov PG
    J Cardiovasc Electrophysiol; 2019 Dec; 30(12):2907-2913. PubMed ID: 31579959
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.